Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papilloma Virus Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03418480
What this trial is testing

HARE-40: HPV Anti-CD40 RNA vaccinE

Who this might be right for
Human Papilloma Virus Related CarcinomaHead and Neck NeoplasmCervical Neoplasm+2 more
University of Southampton 32
Not applicableWithdrawnNCT01551537
What this trial is testing

Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline
Early research (Phase 1)Study completedNCT03929172
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Who this might be right for
Papillomavirus Infections
2A Pharma AB 20
Large-scale testing (Phase 3)WithdrawnNCT02082639
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Post-approval studies (Phase 4)Study completedNCT01031069
What this trial is testing

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 873
Large-scale testing (Phase 3)Study completedNCT00306241
What this trial is testing

Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Not applicableStudy completedNCT02994290
What this trial is testing

Evaluation of the Implementation and Effectiveness of IPP-HPV

Who this might be right for
HPV Vaccination
Yale University 817
Large-scale testing (Phase 3)Study completedNCT01461096
What this trial is testing

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 575
Not applicableStudy completedNCT01489527
What this trial is testing

Preparedness Study - HPV Vaccine

Who this might be right for
Sexual Transmission of Infection
H. Lee Moffitt Cancer Center and Research Institute 406
Large-scale testing (Phase 3)Study completedNCT02567955
What this trial is testing

Immunogenicity and Safety of Gardasil-9 and Cervarix

Who this might be right for
HPV Vaccines Immunogenicity and Safety
Laval University 376
Large-scale testing (Phase 3)Study completedNCT01190189
What this trial is testing

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 137
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06882447
What this trial is testing

QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer Stage IVB
Northern Jiangsu People's Hospital 35
Large-scale testing (Phase 3)UnknownNCT05580341
What this trial is testing

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Who this might be right for
Cervical CancerGenital WartCIN+2 more
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Not applicableStudy completedNCT01284374
What this trial is testing

Parent-son-provider Decision-making About HPV Vaccination

Who this might be right for
Human Papillomavirus Vaccination
Indiana University 62
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Large-scale testing (Phase 3)Study completedNCT01249365
What this trial is testing

The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 199
Not applicableLooking for participantsNCT07248904
What this trial is testing

The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions

Who this might be right for
Human Papillomavirus (HPV)Papillomavirus VaccinesHealth Knowledge, Attitudes, Practice+2 more
Cukurova University 88
Not applicableUnknownNCT06361628
What this trial is testing

Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine

Who this might be right for
VaccinationHealth SystemsKnowledge, Attitudes, Practice
University Medical Center Groningen 1,000
Early research (Phase 1)UnknownNCT05672966
What this trial is testing

Phase I Clinical Trial of a Candidate HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Wuhan BravoVax Co., Ltd. 40
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Next Page